The most exciting research on the aspirin-cancer connection came last year, when three related studies were published simultaneously in The Lancet and The LancetOncology.
Compared to the U.S., breast cancer mortality is 9% higher in Canada (according to the government statistics of each country), 52% higher in Germany and 88% higher in the United Kingdom (according to studies published in LancetOncology).